Loading clinical trials...
Loading clinical trials...
Qsymia (Phentermine-topiramate) to Reduce Binge Eating/Purging in Patients With Bulimia Nervosa and Binge Eating Disorder
Conditions
Interventions
Phentermine/Topiramate-First
Placebo
Locations
1
United States
Stanford School of Medicine, Psychiatry and Behavioral Sciences
Stanford, California, United States
Start Date
October 30, 2015
Primary Completion Date
February 23, 2017
Completion Date
April 15, 2017
Last Updated
May 14, 2018
NCT07478510
NCT05995496
NCT05614024
NCT04806620
NCT05304104
NCT07212673
Lead Sponsor
Stanford University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions